Dario Alba
commented on
$Zeo Energy (ZEO.US)$ this stock can go south at any time.
1
Dario Alba
Set a live reminder
Trump Inauguration Investment Special
Jan 22 02:00
142
19
10
Dario Alba
commented on
$Powell Max (PMAX.US)$
Powell Max - $4,521 Billion Addressable Market Acquisition Strategy
Wednesday, 15th January at 4:00 pm
HONG KONG, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Powell Max Limited (NASDAQ: PMAX) (the "Company" or "Powell Max"), a financial communications services provider headquartered in Hong Kong, today announced that it has commenced activities to pursue acquisitions as part of its strategy to build and grow its business operations. The Company is currently evaluating several oth...
Powell Max - $4,521 Billion Addressable Market Acquisition Strategy
Wednesday, 15th January at 4:00 pm
HONG KONG, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Powell Max Limited (NASDAQ: PMAX) (the "Company" or "Powell Max"), a financial communications services provider headquartered in Hong Kong, today announced that it has commenced activities to pursue acquisitions as part of its strategy to build and grow its business operations. The Company is currently evaluating several oth...
1
4
Dario Alba
commented on
$RAPT Therapeutics (RAPT.US)$ chances it going $3? is this a long time hold or short.
1
Dario Alba
liked
$Nukkleus (NUKK.US)$ buy now or regret later
2
4
Dario Alba
liked
$BioAtla (BCAB.US)$
BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting
Monday, 16th December at 8:00 am
Improved median overall survival (OS) for Mec-V treated patients with treatment-refractory non-small cell lung cancer (NSCLC) expressing mutated KRAS (mKRAS) as compared to Mec-V treated patient with treat...
BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting
Monday, 16th December at 8:00 am
Improved median overall survival (OS) for Mec-V treated patients with treatment-refractory non-small cell lung cancer (NSCLC) expressing mutated KRAS (mKRAS) as compared to Mec-V treated patient with treat...
1
$Banzai International (BNZI.US)$ really a bad investment
Dario Alba
commented on
$Safe Pro Group (SPAI.US)$ this is one of those stocks which you should avoid trading, someone's playground
1
2
Dario Alba OP : I told you so...